Cox regression analysis of melanoma specific mortality for metastatic melanoma archival tissue samples
| Clinicopathological factors | Univariate analysis | Multivariate analysis | ||
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Age at diagnosis (yr) | 1.03 (1.00–1.07) | 0.053 | 1.03 (1.01–1.06) | 0.01 |
| Gender | ||||
| Female | 1 | |||
| Male | 1.27 (0.55–2.94) | 0.579 | ||
| Site of metastatic melanoma | ||||
| Lymph node | 1 | 1 | ||
| Other sitesa | 1.95 (0.86–4.41) | 0.108 | 2.29 (1.10–4.75) | 0.026 |
| p63 status | ||||
| Negative | 1 | 1 | 0.014 | |
| Positive | 3.27 (1.08–9.87) | 0.035 | 3.86 (1.31–11.39) | |
| Clinicopathological factors | Univariate analysis | Multivariate analysis | ||
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Age at diagnosis (yr) | 1.03 (1.00–1.07) | 0.053 | 1.03 (1.01–1.06) | 0.01 |
| Gender | ||||
| Female | 1 | |||
| Male | 1.27 (0.55–2.94) | 0.579 | ||
| Site of metastatic melanoma | ||||
| Lymph node | 1 | 1 | ||
| Other sitesa | 1.95 (0.86–4.41) | 0.108 | 2.29 (1.10–4.75) | 0.026 |
| p63 status | ||||
| Negative | 1 | 1 | 0.014 | |
| Positive | 3.27 (1.08–9.87) | 0.035 | 3.86 (1.31–11.39) | |
P-values are from Cox proportional HR.
Skin, lung, parotid, and brain.